The bacteriological and clinical assessment of a new preparation of the treatment of otitis externa in dogs and cats.
D000818:Animals; D001623:Betamethasone / Q000008:administration & dosage* / Q000627:therapeutic use; D002371:Cat Diseases / Q000188:drug therapy* / Q000382:microbiology; D002415:Cats; D004221:Disulfiram / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004283:Dog Diseases / Q000188:drug therapy* / Q000382:microbiology; D004285:Dogs; D004338:Drug Combinations; D004341:Drug Evaluation; D003904:Mitosporic Fungi / Q000302:isolation & purification; D009355:Neomycin / Q000008:administration & dosage* / Q000627:therapeutic use; D010032:Otitis Externa / Q000188:drug therapy / Q000382:microbiology / Q000662:veterinary*; D013210:Staphylococcus / Q000302:isolation & purification
D004338:Drug Combinations; D001623:Betamethasone; D009355:Neomycin; D004221:Disulfiram